You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TTX-080

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Trial in United States (TTX-080, pembrolizumab, cetuximab)

Recruiting
  • Cancer
  • TTX-080
  • +2 more
  • Tucson, Arizona
  • +33 more
Aug 3, 2022

Advanced Solid Tumor Trial in Boston (TTX-MC138-NODAGA-Cu64)

Recruiting
  • Advanced Solid Tumor
  • Boston, Massachusetts
    Massachusetts General Hospital
Jun 14, 2023

Solid Tumor, Adult Trial in Korea, Republic of, United States (TTX-030, budigalimab and mFOLFOX6, TTX-030, budigalimab and

Active, not recruiting
  • Solid Tumor, Adult
  • TTX-030, budigalimab and mFOLFOX6
  • +7 more
  • Scottsdale, Arizona
  • +31 more
Oct 18, 2022

Pancreatic Cancer Trial (TTX-030, nab-paclitaxel and gemcitabine, TTX-030, budigalimab, nab-paclitaxel and gemcitabine,

Not yet recruiting
  • Pancreatic Cancer
  • TTX-030, nab-paclitaxel and gemcitabine
  • +2 more
  • (no location specified)
Nov 3, 2023

Postoperative Hypoparathyroidism, Thyroid Tumors, Thyroid Cancer Trial in Nashville (NIRAF Detection Technology)

Recruiting
  • Postoperative Hypoparathyroidism
  • +2 more
  • NIRAF Detection Technology
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Apr 11, 2022

Thyroid Tumors, Thyroid Diseases, Hypoparathyroidism Trial in Ann Arbor (PTeye)

Recruiting
  • Thyroid Neoplasms
  • +8 more
  • PTeye
  • Ann Arbor, Michigan
    The University of Michigan
Jan 5, 2022

Chemo-induced Peripheral Neuropathy (CIPN) Trial (SON-080)

Not yet recruiting
  • Chemotherapy-induced Peripheral Neuropathy (CIPN)
  • SON-080
  • (no location specified)
Jun 23, 2022

TQT Study Trial in Tempe (Tetrodotoxin, Placebos)

Completed
  • TQT Study
  • Tempe, Arizona
    Celerion
Sep 6, 2019

Anemia of Chronic Kidney Disease Trial in Czechia, Germany (PRS-080#022-DP, PRS-080-Placebo#001)

Completed
  • Anemia of Chronic Kidney Disease
  • PRS-080#022-DP
  • PRS-080-Placebo#001
  • Brno, Czechia
  • +5 more
Oct 17, 2019

Operable Breast Cancer Trial in India (0.5% lignocaine 60mM)

Active, not recruiting
  • Operable Breast Cancer
  • 0.5% lignocaine 60mM
  • Guwahati, Assam, India
  • +10 more
Mar 21, 2022

Pain, Peripheral Neuropathy, Neuropathic Pain Trial in United States (Placebo, Tetrodotoxin)

Terminated
Has Results
  • Pain
  • +2 more
  • Fountain Valley, California
  • +22 more
Oct 5, 2018

Anemia of Chronic Kidney Disease Trial in Berlin, Munich (PRS-080#022-DP, PRS-080-Placebo#001)

Unknown status
  • Anemia of Chronic Kidney Disease
  • PRS-080#022-DP
  • PRS-080-Placebo#001
  • Berlin, Germany
  • +1 more
Oct 19, 2017

Deep Vein Thrombosis Trial in Chelyabinsk (Sodium Enoxaparine)

Completed
Has Results
  • Deep Vein Thrombosis
  • Sodium Enoxaparine
  • Chelyabinsk, Russian Federation
    Railroad Clinical Hospital at the station Chelyabinsk
Aug 31, 2016

Healthy Trial in Neu-Ulm (PRS-080#022-DP, PRS-080-Placebo#001)

Completed
  • Healthy
  • Neu-Ulm, Germany
    Nuvisan GmbH
Aug 7, 2015

Pain, Cancer Trial in Vancouver (Tetrodotoxin, Placebo)

Completed
  • Pain
  • Cancer
  • Tetrodotoxin
  • Placebo
  • Vancouver, British Columbia, Canada
    WEX Pharmaceuticals Inc.
Jul 7, 2014

Pain, Cancer Trial in Vancouver (Tetrodotoxin)

Completed
  • Pain
  • Cancer
  • Tetrodotoxin
  • Vancouver, British Columbia, Canada
    WEX Pharmaceuticals Inc.
Oct 22, 2012

Healthy Trial in Tacoma (Tetrodotoxin, )

Completed
  • Healthy
  • Tacoma, Washington
    Comprehensive Clinical Research
Feb 7, 2012

Metastatic Breast Cancer Trial in China (Megestrol acetate, exemestane (Aromasin))

Completed
Has Results
  • Metastatic Breast Cancer
  • Megestrol acetate
  • exemestane (Aromasin)
  • Beijing, China
  • +6 more
May 3, 2011